Andre Matta

Andre Matta is an experienced medical professional specializing in neurology, currently serving as Executive Director at Ventus Therapeutics since February 2024. Prior roles include Senior Director at Eisai US and Director of Clinical Research at Sanofi, where responsibilities encompassed managing multicenter trials for multiple sclerosis. Andre served as Associate Professor at Universidade Federal Fluminense, leading the Neuroimmunology service, and held positions at Biogen and Harvard Medical School focused on medical affairs and clinical research in multiple sclerosis. Andre’s career began as Director at SARAH network of Rehabilitation Hospitals and included project management for phase 3 trials at Servier. Educational achievements include advanced degrees from Universidade Federal Fluminense and training at Harvard University in neurology and multiple sclerosis.